Today's COVID-19 News: April 3, 2020

COVID-19 Therapeutics: Summary of Recently Published Clinical Study using Hydroxychloroquine

Hydroxychloroquine sulphate (Plaquenil) an analog of chloroquine has an established track record for treating malaria and has demonstrated in vitro activity against the SARS-CoV and therefore being considered as possible treatment for COVID-19. Read more...

ERT Enables Clinical Trial Continuity through At-Home Respiratory Solutions

ERT announced multiple options that enable trained healthcare professionals to advance respiratory clinical trials by collecting high-quality spirometry data during patient home visits. Read more...

Zymewire Launches Clinical Development Services for COVID-19 Research

Zymewire, a SaaS company, announced the launch of CovidCollaborators.org, an online directory of expert, pro-bono, and discounted clinical development services being offered in the fight against COVID-19. Read more…